Dr. Elwir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 860
Dallas, TX 75246Phone+1 214-820-8500
Summary
- Dr. Saleh Elwir is a gastroenterologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from University of Jordan Faculty of Medicine and has been in practice 8 years. He specializes in hepatology & liver transplantation and is experienced in transplant hepatology.
Education & Training
- University of MinnesotaFellowship, Gastroenterology, 2013 - 2016
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2010 - 2013
- University of Jordan Faculty of MedicineClass of 2009
Certifications & Licensure
- TX State Medical License 2016 - 2026
- PA State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 14 citationsFactors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium.Mary E Rinella, Sanjaya K Satapathy, Danielle Brandman, Coleman Smith, Sal Elwir
Clinical Gastroenterology and Hepatology. 2023-02-01 - 54 citationsCurrent Status of Liver Allocation in the United States.Saleh Elwir, John R. Lake
Gastroenterology & Hepatology. 2016-03-01 - 20 citationsRisk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.Aldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, Bettina E Hansen, Gideon Hirschfield
Journal of Hepatology. 2022-07-01
Press Mentions
- Hospital Protocol Reduces Mortality from Hepatic EncephalopathyJuly 23rd, 2018
- Baylor Leads the Way in Studies to Combat the Toll of Fatty Liver DiseaseJanuary 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: